I63
Conditions
Interventions
Group 1: In the first study arm patients aged between 18-85 years with unilateral Media infarction within the last 96-144 hrs are included who have given their consent for study participation and anon
Sponsors
Universitätsklinikum Freiburg/Neurologie
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Acute middle cerebral artery stroke 96-144 hours after onset Informed consent in study participation and anonymous scientific use of data
Exclusion criteria
Exclusion criteria: Missing cooperation Peripheral arterial occlusive disease Other acute ischemic stroke within he last 3 months High-grade stenosis of internal carotid artery or middle cerebral artery (>50%)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective is the possibility of measurement of cerebral autoregulation from spontaneous fluctuations in blood pressure at the time of the study (96-144h after infarction). For each patient and experimentee the mean autoregulation parameters (correlation coefficient index (CCI) between mean ABP and NIRS signals, HbTot, hbox and HbRed [MxHbTot, MxHbOx, MxHbRed]) in all 52 channels are calculated. On the basis of these average values ??we determine by means of a Wilcoxon-rank-sum-tests whether a separation of the groups and thus a measurement of the cerebral auto regulation is possible. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objective is the description of a spatial disturbance at the time of investigation (96-144 h after infarction). For each group (patients and control group) an average value of the autoregulation parameters in each of the 52 channels is calculated. Based on these mean values??, then the Wilcoxon-rank-sum-test determines whether there is a deviation between the groups for each channel. In this way we can find out whether the disturbance of autoregulation is only present in a sub-region (i.e. single channel) or in larger areas. | — |
Countries
Germany
Contacts
Public ContactMaximilian Oeinck
Universitätsklinikum FreiburgNeurologie
Outcome results
None listed